Doctor profile · Federal record
Dr. Andres Gutierrez Ordonez, M.D.
Infectious Disease Physician (CMS: Infectious Disease) · Huntsville, AL
- NPI 1134452279
- Accepts Medicare
- 25 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
1102 Monroe St Sw
Huntsville, AL 358015029
(256) 469-7200
fax (256) 734-9181 - Mailing address
-
110 Washington St Ne, Apt 202
Huntsville, AL 358018835
Credentials & registration
- NPI registered
- September 2009 — 17 yrs on file
- Profile last updated
- July 16, 2015
- Year of graduation
- 2001 — 25 yrs since
- Specialty taxonomy
- 207RI0200X — NUCC code
- State license (1)
- Alabama #MD.34084
- Medicaid
- AL #171670
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1134452279. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
11,380
Distinct HCPCS
10
Medicare allowed
$407,649
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J1306 |
Injection, inclisiran, 1 mg | 3,692 | 11 | $12 | |
J0875 |
Injection, dalbavancin, 5 mg | 3,000 | 17 | $15 | |
J1569 |
Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | 2,514 | 13 | $45 | |
99233 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 1,144 | 336 | $110 | |
96365 |
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 213 | 69 | $57 | |
99223 |
Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 192 | 186 | $163 | |
J1335 |
Injection, ertapenem sodium, 500 mg | 142 | 17 | $13 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 97 | 61 | $117 | |
99222 |
Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 80 | 78 | $119 | |
96366 |
Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 75 | 14 | $19 |
In context: peer comparison
Among 5 peers in this city , average services per provider: 725. This provider delivers 16× the peer median.Open Payments
Industry payments received
All-time total
$567
Transactions
7
Manufacturers
4
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| La Jolla Pharmaceutical Company | 3 | $247.33 | |
| Astellas Pharma US Inc | 2 | $178.99 | |
| ViiV Healthcare Company | 1 | $117.72 | |
| Paratek Pharmaceuticals, Inc. | 1 | $23.30 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
393
Patients
59
Total drug cost
$151,307
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Daptomycin | Generic | 79 | 18 | $51,550 |
| Ceftriaxone (Ceftriaxone Sodium) | Brand | 68 | 14 | $5,533 |
| Sodium Chloride (0.9 % Sodium Chloride) | Brand | 40 | 0 | $343 |
| Doxycycline Hyclate | Generic | 28 | 14 | $2,826 |
| Cefepime Hcl | Generic | 23 | 0 | $7,344 |
| Ertapenem (Ertapenem Sodium) | Brand | 23 | 0 | $12,976 |
| Vancomycin Hcl | Generic | 20 | 0 | $1,789 |
| Levofloxacin | Generic | 19 | 13 | $204 |
| Amoxicillin-Clavulanate Potass (Amoxicillin/Potassium Clav) | Brand | 14 | 0 | $489 |
| Cefadroxil | Generic | 14 | 0 | $449 |
Hospital affiliations
Frequently asked questions
What is Dr. Andres Gutierrez Ordonez's medical specialty?
Dr. Andres Gutierrez Ordonez practices Infectious Disease Physician in Huntsville, AL.
Where does Dr. Andres Gutierrez Ordonez practice?
Dr. Andres Gutierrez Ordonez practices at 1102 Monroe St Sw, Huntsville, AL 358015029. Office phone: 2564697200.
What is Dr. Andres Gutierrez Ordonez's NPI?
Dr. Andres Gutierrez Ordonez's National Provider Identifier (NPI) is 1134452279, issued by NPPES.
Does Dr. Andres Gutierrez Ordonez accept Medicare assignment?
Yes. Dr. Andres Gutierrez Ordonez accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Andres Gutierrez Ordonez commonly perform?
Top Medicare-reported procedures in 2023: Injection, inclisiran, 1 mg (HCPCS J1306); Injection, dalbavancin, 5 mg (HCPCS J0875); Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg (HCPCS J1569). Source: CMS Medicare Physician & Other Practitioners file.